CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.24 Billion USD | 18.7% |
| 2022 | 1.04 Billion USD | 3.45% |
| 2021 | 1.01 Billion USD | 17.18% |
| 2020 | 862.45 Million USD | -9.7% |
| 2019 | 955.09 Million USD | 11.11% |
| 2018 | 859.63 Million USD | 7.94% |
| 2017 | 796.39 Million USD | 4.31% |
| 2016 | 763.52 Million USD | 6.17% |
| 2015 | 719.16 Million USD | -2.08% |
| 2014 | 734.46 Million USD | -2.95% |
| 2013 | 756.75 Million USD | -1.35% |
| 2012 | 767.14 Million USD | 5.8% |
| 2011 | 725.07 Million USD | 1.59% |
| 2010 | 713.72 Million USD | 2.73% |
| 2009 | 694.73 Million USD | -6.39% |
| 2008 | 742.18 Million USD | 6.9% |
| 2007 | 694.28 Million USD | 7.34% |
| 2006 | 646.81 Million USD | 4.78% |
| 2005 | 617.3 Million USD | 10.55% |
| 2004 | 558.38 Million USD | 12.32% |
| 2003 | 497.13 Million USD | 9.73% |
| 2002 | 453.06 Million USD | 5.68% |
| 2001 | 428.72 Million USD | 9.3% |
| 2000 | 392.23 Million USD | 5.27% |
| 1999 | 372.6 Million USD | 10.76% |
| 1998 | 336.4 Million USD | 143.24% |
| 1997 | 138.3 Million USD | 10.11% |
| 1996 | 125.6 Million USD | 26.1% |
| 1995 | 99.6 Million USD | 40.08% |
| 1994 | 71.1 Million USD | 32.65% |
| 1993 | 53.6 Million USD | 25.82% |
| 1992 | 42.6 Million USD | 10.65% |
| 1991 | 38.5 Million USD | 22.61% |
| 1990 | 31.4 Million USD | 57.79% |
| 1989 | 19.9 Million USD | 40.14% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 311.63 Million USD | -4.71% |
| 2024 Q3 | 316.7 Million USD | -4.25% |
| 2024 Q2 | 330.74 Million USD | 6.13% |
| 2023 Q3 | 304.57 Million USD | -4.12% |
| 2023 Q4 | 327.04 Million USD | 7.38% |
| 2023 FY | 1.24 Billion USD | 18.7% |
| 2023 Q2 | 317.65 Million USD | 7.51% |
| 2023 Q1 | 295.46 Million USD | 17.78% |
| 2022 Q3 | 275.08 Million USD | -0.76% |
| 2022 Q4 | 250.86 Million USD | -8.8% |
| 2022 Q1 | 242.32 Million USD | -11.55% |
| 2022 FY | 1.04 Billion USD | 3.45% |
| 2022 Q2 | 277.19 Million USD | 14.39% |
| 2021 Q2 | 255.16 Million USD | 9.66% |
| 2021 Q1 | 232.67 Million USD | -7.97% |
| 2021 Q3 | 248.82 Million USD | -2.48% |
| 2021 Q4 | 273.97 Million USD | 10.11% |
| 2021 FY | 1.01 Billion USD | 17.18% |
| 2020 Q4 | 252.82 Million USD | 6.3% |
| 2020 Q3 | 237.83 Million USD | 50.73% |
| 2020 Q2 | 157.78 Million USD | -26.27% |
| 2020 Q1 | 214.01 Million USD | -19.2% |
| 2020 FY | 862.45 Million USD | -9.7% |
| 2019 Q1 | 218.37 Million USD | -9.93% |
| 2019 FY | 955.09 Million USD | 11.11% |
| 2019 Q2 | 238.26 Million USD | 9.11% |
| 2019 Q3 | 233.59 Million USD | -1.96% |
| 2019 Q4 | 264.86 Million USD | 13.39% |
| 2018 FY | 859.63 Million USD | 7.94% |
| 2018 Q2 | 212.82 Million USD | 5.32% |
| 2018 Q1 | 202.06 Million USD | -9.21% |
| 2018 Q4 | 242.44 Million USD | 19.84% |
| 2018 Q3 | 202.3 Million USD | -4.94% |
| 2017 Q3 | 190.11 Million USD | -3.57% |
| 2017 Q1 | 186.56 Million USD | -8.59% |
| 2017 FY | 796.39 Million USD | 4.31% |
| 2017 Q4 | 222.55 Million USD | 17.06% |
| 2017 Q2 | 197.15 Million USD | 5.67% |
| 2016 FY | 763.52 Million USD | 6.17% |
| 2016 Q4 | 204.09 Million USD | 10.45% |
| 2016 Q1 | 181.2 Million USD | -5.14% |
| 2016 Q3 | 184.79 Million USD | -4.47% |
| 2016 Q2 | 193.43 Million USD | 6.75% |
| 2015 FY | 719.16 Million USD | -2.08% |
| 2015 Q3 | 169.18 Million USD | -6.54% |
| 2015 Q4 | 191.01 Million USD | 12.9% |
| 2015 Q2 | 181.02 Million USD | 1.73% |
| 2015 Q1 | 177.94 Million USD | -8.03% |
| 2014 Q1 | 180.59 Million USD | -10.56% |
| 2014 FY | 734.46 Million USD | -2.95% |
| 2014 Q3 | 173.62 Million USD | -7.04% |
| 2014 Q2 | 186.78 Million USD | 3.43% |
| 2014 Q4 | 193.46 Million USD | 11.43% |
| 2013 Q1 | 185.43 Million USD | -7.86% |
| 2013 FY | 756.75 Million USD | -1.35% |
| 2013 Q4 | 201.9 Million USD | 13.54% |
| 2013 Q3 | 177.82 Million USD | -7.18% |
| 2013 Q2 | 191.58 Million USD | 3.32% |
| 2012 FY | 767.14 Million USD | 5.8% |
| 2012 Q3 | 181.88 Million USD | -4.12% |
| 2012 Q2 | 189.69 Million USD | -2.38% |
| 2012 Q1 | 194.31 Million USD | 4.71% |
| 2012 Q4 | 201.24 Million USD | 10.64% |
| 2011 Q4 | 185.57 Million USD | 7.39% |
| 2011 FY | 725.07 Million USD | 1.59% |
| 2011 Q2 | 183.23 Million USD | -0.12% |
| 2011 Q3 | 172.81 Million USD | -5.69% |
| 2011 Q1 | 183.45 Million USD | -0.34% |
| 2010 Q2 | 181.08 Million USD | 2.68% |
| 2010 Q3 | 172.19 Million USD | -4.91% |
| 2010 Q4 | 184.07 Million USD | 6.9% |
| 2010 FY | 713.72 Million USD | 2.73% |
| 2010 Q1 | 176.36 Million USD | -7.48% |
| 2009 Q2 | 164.56 Million USD | 0.31% |
| 2009 FY | 694.73 Million USD | -6.39% |
| 2009 Q4 | 190.63 Million USD | 8.64% |
| 2009 Q3 | 175.47 Million USD | 6.63% |
| 2009 Q1 | 164.06 Million USD | -8.47% |
| 2008 Q4 | 179.24 Million USD | -0.09% |
| 2008 Q3 | 179.4 Million USD | -6.92% |
| 2008 Q2 | 192.75 Million USD | 1.04% |
| 2008 Q1 | 190.77 Million USD | 0.64% |
| 2008 FY | 742.18 Million USD | 6.9% |
| 2007 Q3 | 164.44 Million USD | -2.84% |
| 2007 Q2 | 169.25 Million USD | -1.03% |
| 2007 FY | 694.28 Million USD | 7.34% |
| 2007 Q4 | 189.56 Million USD | 15.28% |
| 2007 Q1 | 171.01 Million USD | 0.66% |
| 2006 Q4 | 169.89 Million USD | 9.62% |
| 2006 FY | 646.81 Million USD | 4.78% |
| 2006 Q3 | 154.98 Million USD | -5.19% |
| 2006 Q2 | 163.47 Million USD | 3.16% |
| 2006 Q1 | 158.46 Million USD | 3.44% |
| 2005 FY | 617.3 Million USD | 10.55% |
| 2005 Q4 | 153.2 Million USD | 2.15% |
| 2005 Q3 | 149.97 Million USD | -5.25% |
| 2005 Q2 | 158.27 Million USD | 1.55% |
| 2005 Q1 | 155.85 Million USD | -3.33% |
| 2004 Q1 | 133.96 Million USD | 0.12% |
| 2004 Q4 | 161.22 Million USD | 21.87% |
| 2004 Q2 | 130.91 Million USD | -2.28% |
| 2004 Q3 | 132.28 Million USD | 1.05% |
| 2004 FY | 558.38 Million USD | 12.32% |
| 2003 Q2 | 124.54 Million USD | 5.51% |
| 2003 Q4 | 133.8 Million USD | 10.82% |
| 2003 Q1 | 118.03 Million USD | 2.41% |
| 2003 FY | 497.13 Million USD | 9.73% |
| 2003 Q3 | 120.74 Million USD | -3.05% |
| 2002 FY | 453.06 Million USD | 5.68% |
| 2002 Q1 | 113.2 Million USD | -0.11% |
| 2002 Q2 | 111.26 Million USD | -1.71% |
| 2002 Q3 | 113.33 Million USD | 1.85% |
| 2002 Q4 | 115.25 Million USD | 1.7% |
| 2001 Q1 | 105.9 Million USD | 4.44% |
| 2001 FY | 428.72 Million USD | 9.3% |
| 2001 Q4 | 113.32 Million USD | 7.6% |
| 2001 Q3 | 105.31 Million USD | 1.1% |
| 2001 Q2 | 104.17 Million USD | -1.64% |
| 2000 FY | 392.23 Million USD | 5.27% |
| 2000 Q1 | 101.91 Million USD | 2.43% |
| 2000 Q2 | 96.98 Million USD | -4.83% |
| 2000 Q3 | 91.92 Million USD | -5.22% |
| 2000 Q4 | 101.4 Million USD | 10.32% |
| 1999 Q1 | 90.9 Million USD | 1.11% |
| 1999 Q2 | 90.5 Million USD | -0.44% |
| 1999 Q4 | 99.5 Million USD | 8.51% |
| 1999 Q3 | 91.7 Million USD | 1.33% |
| 1999 FY | 372.6 Million USD | 10.76% |
| 1998 Q3 | 85.7 Million USD | 6.46% |
| 1998 FY | 336.4 Million USD | 143.24% |
| 1998 Q2 | 80.5 Million USD | 0.37% |
| 1998 Q4 | 89.9 Million USD | 4.9% |
| 1998 Q1 | 80.2 Million USD | 113.87% |
| 1997 Q1 | 31.5 Million USD | -5.12% |
| 1997 Q3 | 38.6 Million USD | 25.73% |
| 1997 Q2 | 30.7 Million USD | -2.54% |
| 1997 Q4 | 37.5 Million USD | -2.85% |
| 1997 FY | 138.3 Million USD | 10.11% |
| 1996 Q3 | 31.4 Million USD | -1.26% |
| 1996 Q1 | 29.2 Million USD | 5.42% |
| 1996 Q4 | 33.2 Million USD | 5.73% |
| 1996 FY | 125.6 Million USD | 26.1% |
| 1996 Q2 | 31.8 Million USD | 8.9% |
| 1995 Q1 | 19.8 Million USD | 7.03% |
| 1995 Q4 | 27.7 Million USD | 5.32% |
| 1995 Q3 | 26.3 Million USD | 1.54% |
| 1995 FY | 99.6 Million USD | 40.08% |
| 1995 Q2 | 25.9 Million USD | 30.81% |
| 1994 Q1 | 17.8 Million USD | 0.0% |
| 1994 FY | 71.1 Million USD | 32.65% |
| 1994 Q4 | 18.5 Million USD | 6.94% |
| 1994 Q3 | 17.3 Million USD | -1.14% |
| 1994 Q2 | 17.5 Million USD | -1.69% |
| 1993 Q3 | 14.9 Million USD | 44.66% |
| 1993 Q4 | 17.8 Million USD | 19.46% |
| 1993 FY | 53.6 Million USD | 25.82% |
| 1993 Q1 | 10.6 Million USD | -2.75% |
| 1993 Q2 | 10.3 Million USD | -2.83% |
| 1992 Q2 | 11.1 Million USD | 5.71% |
| 1992 Q1 | 10.5 Million USD | -0.94% |
| 1992 FY | 42.6 Million USD | 10.65% |
| 1992 Q3 | 10.1 Million USD | -9.01% |
| 1992 Q4 | 10.9 Million USD | 7.92% |
| 1991 FY | 38.5 Million USD | 22.61% |
| 1991 Q1 | 8.5 Million USD | 13.33% |
| 1991 Q4 | 10.6 Million USD | 8.16% |
| 1991 Q3 | 9.8 Million USD | 1.03% |
| 1991 Q2 | 9.7 Million USD | 14.12% |
| 1990 Q2 | 8 Million USD | 0.0% |
| 1990 FY | 31.4 Million USD | 57.79% |
| 1990 Q4 | 7.5 Million USD | -5.06% |
| 1990 Q3 | 7.9 Million USD | -1.25% |
| 1990 Q1 | 8 Million USD | 21.21% |
| 1989 Q2 | 4.4 Million USD | 12.82% |
| 1989 Q4 | 6.6 Million USD | 29.41% |
| 1989 FY | 19.9 Million USD | 40.14% |
| 1989 Q1 | 3.9 Million USD | 8.33% |
| 1989 Q3 | 5.1 Million USD | 15.91% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 96.906% |
| Allurion Technologies Inc. | 53.46 Million USD | -2220.972% |
| Artivion, Inc. | 354 Million USD | -250.548% |
| Avanos Medical, Inc. | 673.3 Million USD | -84.309% |
| Butterfly Network, Inc. | 65.9 Million USD | -1783.086% |
| Butterfly Network, Inc. | 65.9 Million USD | -1783.086% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | 53.544% |
| Boston Scientific Corporation | 14.24 Billion USD | 91.285% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -17368.384% |
| Edwards Lifesciences Corporation | 6 Billion USD | 79.334% |
| Paragon 28, Inc. | 216.38 Million USD | -473.483% |
| Glaukos Corporation | 314.71 Million USD | -294.315% |
| Globus Medical, Inc. | 1.56 Billion USD | 20.882% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -98.617% |
| Integer Holdings Corporation | 1.59 Billion USD | 22.279% |
| Medtronic plc | 32.36 Billion USD | 96.166% |
| Nevro Corp. | 425.17 Million USD | -191.87% |
| Owlet, Inc. | 54.01 Million USD | -2197.637% |
| Penumbra, Inc. | 1.05 Billion USD | -17.235% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | 77.636% |
| Sonendo, Inc. | 43.86 Million USD | -2729.03% |
| STERIS plc | 5.13 Billion USD | 75.851% |
| Stryker Corporation | 20.49 Billion USD | 93.946% |
| Vapotherm, Inc. | 68.66 Million USD | -1707.153% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 83.217% |